| Identification | Back Directory | [Name]
Vonoprazan Fumarate impurity | [CAS]
1885094-62-1 | [Synonyms]
Vonoprazan-19
Vonoprazan-014
Vonoprazan Impurity U9
Vonoprazan Impuirty U6
Vonoprazan Impurity 67
TAK438 Impurity 9 Monomer
Vonoprazan Fumarate impurity
Vonoprazan Impurity 9 Monomer
N,N-Dimethylmethanamine Vonoprazan
5-(3-fluorophenyl)-1H-pyrrole-3-carbonitrile
1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-...
(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)methanol
(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)methanamine
5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carboxylic acid
1H-Pyrrole-3-methanamine, 5-(2-fluorophenyl)-N,N-dimethyl-1-(3-pyridinylsulfonyl)-
1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N,N-dimethylmethanamine
N-((5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)methyl)-N-methylaspartic acid
N-((5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)methyl)-N-methylhydroxylamine
1-(1-((1,6-dihydropyridin-3-yl)sulfonyl)-5-(2-fluorophenyl)-1H-pyrrol-3-yl)-N-methylmethanamine
5-((2-(2-fluorophenyl)-4-((methylamino)methyl)-1H-pyrrol-1-yl)sulfonyl)-1,2,3,4-tetrahydropyridin-2-ol
1-(5-(2-fluorophenyl)-1H-pyrrol-3-yl)-N-((5-(2-fluorophenyl)-1H-pyrrol-3-yl)methyl)-N-methylmethanamine
Vonoprazan impurity 17/1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N,N- dimethylmethanamine
1-(5-(2-fluorophenyl)-1-((1,4,5,6-tetrahydropyridin-3-yl)sulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine fumarate
1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-((5-(2-fluorophenyl)-1H-pyrrol-3-yl)methyl)-N-methylmethanamine
1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-((5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)methyl)-N-methylmethanamine | [Molecular Formula]
C18H18FN3O2S | [MDL Number]
MFCD34472183 | [MOL File]
1885094-62-1.mol | [Molecular Weight]
359.42 |
| Hazard Information | Back Directory | [Uses]
N,N-Dimethylmethanamine Vonoprazan is an impurity of Vonoprazan a novel potassium-?competitive acid blocker for the treatment of acid-?related diseases. |
|
|